Care Delivery

This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.

New obesity statistics highlight importance of preventive cardiology
Cardiovascular health is much worse in some parts of the United States than others. Cardiologists in those high-risk areas can make a world of difference by embracing preventive cardiology and working to treat patients before it is too late.
New dyslipidemia guideline puts add-on testing, early screening in the spotlight
The updated recommendations represent a collaboration between the American College of Cardiology, American Heart Association and several other U.S. healthcare organizations.
High costs may be keeping working-age heart patients from seeking care
When working-age adults develop cardiovascular disease, it often ends up eating up a significant amount of their income. Are insurance companies doing enough to help these patients?
Vascular surgeons deliver major value in terms of patient outcomes and health system profitability
Vascular surgeons play a critical role in today's evolving healthcare landscape. However, researchers noted, they often do not get the respect or appreciation they deserve.
A ‘disquieting plateau’: Healthcare costs are up, but survival among heart patients stays the same
The cardiovascular mortality rate in the United States decreased dramatically from 2000 to 2011. Since then, however, it has remained relatively unchanged.

Newsweek ranked the 50 best heart hospitals in the world

Heart health experts explore CT’s role in the diagnosis of CAD in women

Leslee J. Shaw, PhD, and Martha Gulati, MD, are joining forces to discuss how CAD presents in women, advances in imaging technology and much more.

Mark Cuban to CEOs: ‘If you’re using a Big 3 pharmacy benefits manager, you are getting ripped off. Period. End of story.’

The White House held a roundtable discussion on lowering healthcare costs last week. Fortune magazine followed up with one of the panelists, business mogul and Cost Plus Drugs cofounder Mark Cuban.

Transparency report called ‘irresponsible,’ ‘reckless’

Have hospitals really taken a step backward along their march toward price transparency? Or is the watchdog outfit making the claim playing fast and loose with the facts?

semaglutide wegovy Novo Nordisk major adverse cardiovascular events

A big win for Wegovy: Weight loss drug semaglutide first in history to gain FDA approval for reducing heart risks

The FDA made a special announcement about its decision, describing the news as "a major advance for public health."

Change Healthcare cyberattack: A recap and update in 10 quotes

“This is what happens when everything merges and you only have one option.”

Some older patients taking aspirin to prevent CVD may be doing more harm than good

“Aspirin is no longer a one-size-fits-all preventive tool for older adults," according to one specialist with Michigan Medicine.

The rapid rise of artificial intelligence (AI) has helped cardiologists, radiologists, nurses and other healthcare providers embrace precision medicine in a way that ensures more heart patients are receiving personalized care.

AI helps cardiologists deliver personalized healthcare—but there is still plenty of work to do

A new scientific statement from the American Heart Association explores the many ways AI and machine learning are being used to improve care for heart patients.

FDA announces new Class I recall of drainage systems after 26 injuries

According to the agency, using these devices “may cause serious injuries or death.”

Care Delivery

New obesity statistics highlight importance of preventive cardiology

New dyslipidemia guideline puts add-on testing, early screening in the spotlight

High costs may be keeping working-age heart patients from seeking care

Vascular surgeons deliver major value in terms of patient outcomes and health system profitability

A ‘disquieting plateau’: Healthcare costs are up, but survival among heart patients stays the same